BioNexus Gene Lab Corp. Operating Income
BioNexus Gene Lab Corp. (BGLC) reported Operating Income of -$282.40 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- BioNexus Gene Lab Corp. operating income (loss) for the quarter ending 2026-06-30 was -$282.40K.
- BioNexus Gene Lab Corp. operating income (loss) for the quarter ending 2026-03-31 was -$540.49K.
- BioNexus Gene Lab Corp. operating income (loss) for the quarter ending 2025-12-31 was -$1.03M.
- BioNexus Gene Lab Corp. operating income (loss) for the quarter ending 2025-09-30 was -$702.51K.
- BioNexus Gene Lab Corp. operating income (loss) for fiscal 2025 was -$2.97M.
- BioNexus Gene Lab Corp. operating income (loss) for fiscal 2024 was -$1.57M.
- BioNexus Gene Lab Corp. operating income (loss) for fiscal 2023 was -$2.59M.
- BioNexus Gene Lab Corp. operating income (loss) for fiscal 2022 was -$291.18K, a 127.58% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$282.40K 10-Q · filed 2026-08-14 | -$822.89K 10-Q · filed 2026-08-14 | -$1.86M derived: sum of 3 quarters · filed 2026-08-14 | -$2.56M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$540.49K 10-Q · filed 2026-05-15 | -$1.57M derived: sum of 2 quarters · filed 2026-05-15 | -$2.28M derived: sum of 3 quarters · filed 2026-05-15 | -$2.89M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.74M derived: sum of 2 quarters · filed 2026-04-14 | -$2.35M derived: sum of 3 quarters · filed 2026-08-14 | -$2.97M 10-K · filed 2026-04-14 | |||
| 2025-09-30 | -$702.51K 10-Q · filed 2025-11-14 | -$1.31M derived: sum of 2 quarters · filed 2026-08-14 | -$1.93M 10-Q · filed 2025-11-14 | -$2.35M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$611.29K 10-Q · filed 2026-08-14 | -$1.23M 10-Q · filed 2026-08-14 | -$1.65M derived: sum of 3 quarters · filed 2026-08-14 | -$2.98M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$618.42K 10-Q · filed 2026-05-15 | -$1.03M derived: sum of 2 quarters · filed 2026-05-15 | -$2.37M derived: sum of 3 quarters · filed 2026-05-15 | -$2.11M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$416.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$1.75M derived: sum of 2 quarters · filed 2026-04-14 | -$1.49M derived: sum of 3 quarters · filed 2026-04-14 | -$1.57M 10-K · filed 2026-04-14 | |||
| 2024-09-30 | -$1.34M 10-Q · filed 2025-11-14 | -$1.08M derived: sum of 2 quarters · filed 2025-11-14 | -$1.16M 10-Q · filed 2025-11-14 | -$899.73K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $259.17K 10-Q · filed 2025-08-18 | $180.14K 10-Q · filed 2025-08-18 | $437.89K derived: sum of 3 quarters · filed 2025-08-18 | -$2.09M derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | -$79.03K 10-Q · filed 2025-05-15 | $178.73K derived: sum of 2 quarters · filed 2025-05-15 | -$2.35M derived: sum of 3 quarters · filed 2025-05-15 | -$2.62M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $257.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$2.27M derived: sum of 2 quarters · filed 2025-04-15 | -$2.54M derived: sum of 3 quarters · filed 2025-04-15 | -$2.59M 10-K · filed 2025-04-15 | |||
| 2023-09-30 | -$2.53M 10-Q · filed 2024-11-15 | -$2.80M derived: sum of 2 quarters · filed 2024-11-15 | -$2.85M 10-Q · filed 2024-11-15 | -$2.97M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | -$272.20K 10-Q · filed 2024-08-14 | -$322.83K 10-Q · filed 2024-08-14 | -$445.52K derived: sum of 3 quarters · filed 2024-08-14 | -$510.73K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$50.63K 10-Q · filed 2024-05-15 | -$173.32K derived: sum of 2 quarters · filed 2024-05-15 | -$238.53K derived: sum of 3 quarters · filed 2024-05-15 | -$376.50K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$122.69K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$187.90K derived: sum of 2 quarters · filed 2024-04-16 | -$325.87K derived: sum of 3 quarters · filed 2024-04-16 | -$291.18K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$65.22K 10-Q/A · filed 2024-03-26 | -$203.18K derived: sum of 2 quarters · filed 2024-03-26 | -$168.49K 10-Q/A · filed 2024-03-26 | $32.58K derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2022-06-30 | -$137.96K 10-Q · filed 2023-08-16 | -$103.27K 10-Q · filed 2023-08-16 | $97.79K derived: sum of 3 quarters · filed 2023-08-16 | $470.43K derived: sum of 4 quarters · filed 2023-08-16 | |||
| 2022-03-31 | $34.69K 10-Q · filed 2023-05-09 | $235.75K derived: sum of 2 quarters · filed 2023-05-09 | $608.39K derived: sum of 3 quarters · filed 2023-05-09 | $748.38K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $201.06K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $573.70K derived: sum of 2 quarters · filed 2023-03-31 | $713.69K derived: sum of 3 quarters · filed 2023-03-31 | $1.06M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $372.64K 10-Q · filed 2022-11-14 | $512.63K derived: sum of 2 quarters · filed 2022-11-14 | $854.76K 10-Q · filed 2022-11-14 | $851.69K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $139.99K 10-Q · filed 2022-08-15 | $482.12K 10-Q · filed 2022-08-15 | $479.05K derived: sum of 3 quarters · filed 2022-08-15 | $716.36K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $342.10K 10-Q · filed 2022-05-16 | $339.06K derived: sum of 2 quarters · filed 2022-05-16 | $576.37K derived: sum of 3 quarters · filed 2022-05-16 | $542.39K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$3.04K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $234.27K derived: sum of 2 quarters · filed 2022-04-06 | $200.29K derived: sum of 3 quarters · filed 2022-04-06 | $1.27M 10-K · filed 2022-04-06 | |||
| 2020-09-30 | $237.31K 10-Q · filed 2021-11-15 | -$59.54K 10-Q · filed 2020-11-03 | $203.33K derived: sum of 2 quarters · filed 2021-11-15 | $1.28M 10-Q · filed 2021-11-15 | -$172.69K 10-Q · filed 2020-11-03 | $1.18M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$33.97K 10-Q · filed 2021-08-12 | -$66.05K 10-Q · filed 2020-08-11 | $1.04M 10-Q · filed 2021-08-12 | -$113.14K 10-Q · filed 2020-08-11 | $943.41K derived: sum of 3 quarters · filed 2021-08-12 | $893.27K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $1.07M 10-Q · filed 2021-05-18 | -$47.09K 10-Q · filed 2020-05-08 | $977.38K derived: sum of 2 quarters · filed 2021-05-18 | $927.25K derived: sum of 3 quarters · filed 2021-05-18 | $858.03K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2019-12-31 | -$96.14K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | -$146.28K derived: sum of 2 quarters · filed 2021-03-30 | -$215.50K derived: sum of 3 quarters · filed 2021-03-30 | -$275.70K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$50.14K 10-Q/A · filed 2020-11-09 | -$119.36K derived: sum of 2 quarters · filed 2020-11-09 | -$179.56K 10-Q/A · filed 2020-11-09 | -$242.91K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$69.22K 10-Q · filed 2020-08-11 | -$129.42K 10-Q · filed 2020-08-11 | -$192.77K derived: sum of 3 quarters · filed 2020-08-11 | -$247.91K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$60.20K 10-Q · filed 2020-05-08 | -$123.55K derived: sum of 2 quarters · filed 2020-05-08 | -$178.69K derived: sum of 3 quarters · filed 2020-05-08 | -$218.16K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | -$63.35K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$118.49K derived: sum of 2 quarters · filed 2020-03-31 | -$157.96K derived: sum of 3 quarters · filed 2020-03-31 | $59.90K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | -$55.14K 10-Q · filed 2019-11-14 | -$94.61K derived: sum of 2 quarters · filed 2019-11-14 | $123.25K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | -$39.47K 10-Q · filed 2019-08-09 | $178.39K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |